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Cytomegalovirus glomerulopathy: A controversial lesion. Seven autop-
sies performed on immunosuppressed bone marrow transplant recipi-
ents who died with documented herpes virus infection were reviewed.
The kidneys were studied by light and electron microscopy and
revealed no pathological findings, specifically no glomerulopathy or
tubular interstitial nephritis. Seven renal biopsies performed on kidney
transplant recipients in whom a diagnosis of cytomegalovirus glomeru-
lopathy was entertained were also studied. These patients exhibited
clinical parameters suggestive of cytomegalovirus infection. Three
patients had subsequent nephrectomies and two showed severe acute
vascular rejection. The one kidney without demonstrable acute vascu-
lar rejection was negative for cytomegalovirus on culture. Three
additional patients improved or stabilized their renal function under
therapy for rejection. Light, electron microscopic and immunofluores-
cent studies, although confirmatory of endothelial cell damage, did not
substantiate active cytomegalovirus renal infection in these patients.
An additional group of fifteen children with disseminated cytomegalo-
virus infection revealed no evidence of glomerulopathy. Finally, two
kidney transplant recipients with proven cytomegalovirus infection(one with associated tubular interstitial nephritis) also showed no
glomerular alterations. It is the author's opinion that the entity that has
been considered as cytomegalovirus glomerulopathy probably repre-
sents rejection, either a peculiar anti-endothelial type of rejection or a
protracted, early, or partially resolved acute vascular rejection without
residual or identifiable acute vascular rejection changes in the tissue
sampled.
Richardson et al [1] have described a glomerulopathy found
in five transplanted kidneys which they consider to represent an
effect of cytomegalovirus infection (CMV), They emphasized
the importance of separating this lesion from changes associ-
ated with acute rejection. Two of the five allografts with this
peculiar form of glomerulopathy responded to a cessation of
high dose immunosuppressive therapy. An additional patient
had successive episodes of rejection which responded to in-
creased immunosuppression, and CMV glomerulopathy which
responded to decreased immunosuppression.
Harman Ct a! [21 reported seven patients with cytomegalovi-
rus glomerulopathy, but indicated that the lesion had no prog-
nostic significance since the patients responded to immunosup-
pressive therapy for rejection.
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The criteria for recognition of the lesion include a
glomerulopathy, identical or indistinguishable from transplant
glomerulopathy [3, 4] not accompanied by other changes of
acute rejection (i.e., acute vascular rejection findings), occur-
ring in patients with clinically manifest, viremic CMV infection.
In neither of the two studies were CMV inclusions seen within
the tubules or glomeruli. Immunofluorescence for cytomegalo-
virus antigen has been positive in only one of the patients
reported [1].
A study was designed to search for any cases which might
represent this viral—associated glomerulopathy to determine if it
is a specific lesion or whether it represented a peculiar form of
acute rejection.
The search concentrated on four distinct groups of patients.
Group 1—Seven autopsies of bone marrow transplantation
patients who died with documented herpes virus infection (6
CMV, 1 HSV). All organs were studied for evidence of viral
infection with particular emphasis placed upon the kidneys
(Table 1).
Group 2—Autopsies of fifteen children with disseminated
cytomegalovirus infection. Only two of these fifteen children
were pharmacologically immunosuppressed. Nine of these pa-
tients had morphologic evidence of renal involvement by CMV
(Table 2).
Group 3—Seven renal transplant patients in whom a diagnosis
of cytomegalovirus glomerulopathy was entertained, based
upon the previously cited criteria (Table 3).
Group 4—Autopsy of one immunosuppressed kidney trans-
plant recipient with evidence of disseminated cytomegalovirus
infection and one nephrectomy specimen from another renal
transplant recipient with cytomegalovirus tubular interstitial
nephritis.
Clinical data
Group 1—Bone marrow transplantation patients
The records of nineteen patients undergoing bone marrow
transplantation from March 1981 through October 1983 were
reviewed. Seven of the nineteen patients had died with docu-
mented herpes virus infection (6 CMV, I HSV), predominantly
interstitial pneumonia. Five of the seven had leukemia as the
primary disease, and two had aplastic anemia. Six of the seven
had coexistent severe graft versus host disease and were
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Table 1. Group 1, Bone marrow recipients with disseminated herpes infection
Patient Primary Type of Admission Terminal renal Interstitial Graft vs. Herpes
disease transplant renal status status pneumonia host disease culture
Acute BM se cr 1.0 mg% se cr 2.5 mg% Present Severe HSV
myeloblastic 4 days prior (lung & liver)
leukemia to death
2 Acute BM se cr 0.7 mg% se er 2.2 mg% Present Severe CM
lymphoblastic day of death (lung)
leukemia
3 Aplastic BM se cr 1.0 mg% se cr 6.0 mg% Present Severe CMV
anemia with oliguria (lung)
day of death
4 Acute BM se cr 0.9 mg% se cr 2.1 mg% Present Severe CMV
myeloblastic day of death (lung)
leukemia
5 Chronic BM se cr 0.9 mg% se cr 3.9 mg% Present Severe CMV
myelocytic with oliguria (lung)
leukemia day of death
6 Chronic BM se cr 0.9 mg% se cr 9.5 mg% Present Absent CMV
myelocytic with oliguria (lung)
leukemia day of death
7 Aplastic BM se cr 0.9 mg% se cr 1.1 mg% Present Severe CMV
anemia day of death (lung)
Abbreviations are: BM, bone marrow; HSV, herpes virus infection; CMV, cytomegalovinis infection
Table 2. Group 2, Significant data, clinical information and autopsy findings in patients with disseminated CMV
Case # Age Sex Important clinical data Organ involvement by CMV
9 mo. F Contenital CMV — multiple CNS malformations —
septicemia Lungs and placenta
2 10 mo. M CMV — multiple CNS malformations Kidneys
3 6 wk. M Congenital CMV — BKP — DIC Kidneys, liver, lungs, adrenal, pancreas, thyroid
and GI tract
4 Stillborn M CMV Gastrointestinal tract and placenta
5 3 mo. F CMV — cystic fibrosis — BKP — septicemia Minor salivary glands and hypopharynx
6 3 mo. M Congenital CMV — encephalitis, viral Kidneys and lungs
7 42 days F CMV — hyaline membrane disease — intracerebral Lungs
hemorrhage
8 4 mo. F CMV — BKP—septicemia Kidneys and lungs
9 2 days F CMV — Premature — intrauterine growth Kidneys, lungs, pancreas, liver and pituitary
retardation — congenital heart disease
10 5 mo. F CMV Kidneys, lungs and GI tract
11 Stillborn F Congenital CMV — cardiovascular malformations Kidneys, lungs, adrenal glands and liver
12 7 wk. M CMV Lungs
13 Stillborn M Congenital CMV Lungs, kidneys, liver, 01 tract and placenta
14 18 F CMV — S/P cardiac transplantation — Kidneys, lungs and pancreas
immunosuppressed — shock, terminal
15 6 F CMV — aplastic anemia, SIP bone marrow Lungs
transplant — immunosuppressed
Abbreviations are: CMV, cytomegalovirus; CNS, central nervous system; BKP, bronchopneumonia
receiving immunosuppressive therapy. Renal function was nor-
mal in all patients prior to bone marrow transplantation. None
of the patients developed clinically apparent renal dysfunction
except as a preterminal or terminal event secondary to hypo-
tension and/or sepsis (Table 1). Complete autopsies were per-
formed in all seven patients. This study emphasized the changes
found in the kidneys.
Group 2—Patients with disseminated cytomegalovirus
infection
Fifteen autopsies from children who died with disseminated
cytomegalovirus infection were reviewed. Table 2 details din-
ical and pathologic information on these patients. Nine of these
patients had morphologic evidence of renal involvement by
cytomegalovirus.
Group 3—Biopsied tissues on seven renal transplant patients
This group of seven patients had renal biopsies with glomer-
ular changes suggestive of cytomegalovirus glomerulopathy not
associated with acute vascular rejection changes, and with
clinical findings also suggestive of cytomegalovirus
glomerulopathy.
This group can be further broken down into two distinct
subgroups: a) patients with a single renal biopsy, performed
during the post-transplantation period, with subsequent clinical
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Table 3. Group 3, Kidney transplant recipients with changes compatible with "cytomegalovirus glomerulopathy"
Fever, renal function
det. — CMV ab. titer
0, EBV titer 64/day
33
49 days Fever, leukopenia,
renal function det. —
CMV ab. titer
64/day 40, urine
culture positive for
CM V/day 48
19 mo. Fever, renal failure,
leukopenia, CMV
ab. titer 512/approx.
day 570
68 days Fever, cough, upper
res. tract infection
symptoms, low
normal WBC count,
renal funct. det. —
CMV ab. titer
64/day 68
20 days Fever, renal funct.
det. — CMV ab. titer
64/day 13, 32/day 18
44 days Same
Glomerulopathy, no vascular
changes, mt. infiltrates,
acute & chronic, moderate,
no inclusions
Glomerulopathy with lobular
proliferation, segmental
thrombosis in glomerular
capillaries, no vascular
changes, chronic mt.
rejection, mild, no inclusions
Glomerulopathy, chronic
vascular reject., no acute
vascular/mt. reject., no
inclusions
Glomerulopathy, no acute or
chronic vascular or mt.
reject., ATN, no inclusions
Glomerulopathy, no vascular
or mt. reject., no inclusions
Glomerulopathy, acute mt.
reject., mild, no vascular
reject., no inclusions
Glomerulopathy, acute mt.
reject., mild, no vascular
reject., no inclusions
Glomerulopathy, acute in &
capillary reject., no vascular
reject., no inclusions
Same
Glomerulopathy, severe acute
vascular & mt. reject.,
chronic vascular reject., no
inclusions
Glomerulopathy, one vessel
showed acute reject.,
chronic vascular reject., mt.
reject., moderate, no
inclusions
Florid acute vascular rejection
follow up, without nephrectomy; and b) patients with renal
biopsies, followed by nephrectomies.
Group 3a (biopsy only) Case number 1. A 40 year old male
with insulin dependent diabetes meffitus since age 23, under-
went a three antigen match cadavenc transplant without previ-
ous chronic dialysis. Post-transplantation course was
unremarkable until the twenty-sixth day when he developed
spiking fevers which continued for eight days. All viral cultures,
including cerebrospinal fluid, were negative. Renal function
deteriorated during this time and the patient was treated for
rejection with 5 g of intravenous methylprednisolone over five
days. A renal biopsy was done on the thirty-third post-transpian-
tationday. On the day of renal biopsy the CMV antibody titer
was 0, and EBV antibody titer was 64. Renal function improved
following therapy for acute rejection, and stabilized at a serum
creatinine of 2.0 mg%.
Case number 2. A 32 year old male with end stage renal
disease, on chronic hemodialysis, received a 3 antigen, (1
haplotype) match living related donor transplant. His course
was uncomplicated until thirty days post-transplant when he
1 Biopsy 33 days
Case Kidney Time Clinical data at time of# specimen post-trans. biopsy/neph. Microscopic findings IF for CMV EM
2 Biopsy
3 Biopsy
4 Biopsy
5 Biopsy #1
No glomeruli Endotheial damage —
in specimen no viral particles
Negative Endothelial damage —
no viral particles
No glomeruli Endotheial damage —
in specimen no viral particles
Negative Endotheial damage —
no viral particles
— Endotheial damage —
no viral particles
— Same
Negative Same
Negative Endotheial damage —
no viral particles
Negative Same
+1— focal in Endotheial damage —
a few no viral particles
tubules
— Endotheial damage —
noviral particles
Negative Same
Biopsy #2
Nephrectomy 48 days Renal funct. continued
to det., kidney
culture negative for
CMV
Biopsy #1 38 days Fever, renal function
det.
6 Biopsy #2 70 days Fever, renal function
det. — CMV ab. titer
2048/day 74,
1024/day 83
Nephrectomy 80 days Progressive det. of
renal function
7 Biopsy 20 days Fever, renal function
det. — CMV ab. titer
not done
Nephrectomy 52 days Renal function
continued to det.,
kidney culture —
negative for CMV
Abbreviations: IF, immunofluorescence; CMV, cytomegalovirus; EM, endothelial damage; EBV, Epstein—Barr virus; mt., interstitial; det.,
deterioration/deteriorate; reject., rejection; ab., antibody; approx., approximately; funct., function; neph, nephrectomy.
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developed fever, leukopenia, and an increased serum creati-
nine. He received anti-rejection therapy with 3 grams of i.v.
methyiprednisolone over five days. CMV antibody titer on day
40 was 64, urine culture was positive for CMV on day 48. A
renal biopsy was done on day 49. The fever and leukopenia
resolved following the methylprednisolone therapy, renal func-
tion gradually improved to a serum creatinine of 2.0 mg%, and
the patient was discharged on day 57.
Case number 3. A 37 year old male underwent a 2 antigen (1
haplotype) match living related donor renal transplant. During
the first three months he was treated on three occasions for
acute rejection, with stabilization of serum creatinine at 2.9
mg%. Nineteen months after transplantation he was admitted
with fever, pneumonia and renal failure. CMV antibody titer
drawn the day of his admission was 512. The patient admitted to
medical non-compliance. He was initially treated with broad-
spectrum antibiotics and obtained a good clinical response.
Fever recurred, however, and pulmonary infiltrates increased.
Bronchoscopy with transbronchial biopsy was performed but
no specific organisms were identified. The pulmonary condition
improved on oral ampicillin. His renal function, however,
showed no improvement and a renal biopsy was done on the
third hospital day. On the basis of the results of the renal
biopsy, which indicated poor survivability of the kidney, im-
munosuppressive therapy was withdrawn and the patient was
placed on maintenance hemodialysis. Bronchial washing cul-
tures subsequently grew Cryptococcus neoformans.
Case number 4. A nine year old male with Laurence-Moon-
Biedi syndrome and end stage renal disease of unclear etiology
had previously received a living related donor renal transplant
(1 haplotype match) which was lost one day after transplanta-
tion due to hyperacute rejection with renal artery thrombosis
and massive infarction. A second 0 antigen match cadaveric
transplant was performed four days after the transplant
nephrectomy. He was treated for ten days with antilymphocyte
globulin and developed severe serum sickness. He recovered
and was discharged two months after transplantation with a
normal serum creatinine (0,5 mg%). He was readmitted eight
days later (68 days post-transplant) with cough, coryza, and
fever of 103 degrees. CMV antibody titer was 64. White blood
cell count was low normal at this time, blood cultures and chest
x-rays were negative. Urine cultures for CMV were positive.
CMV antibody titer was 4 immediately after the second trans-
plant, prior to his second admission, but had increased to 64 at
the time of his last admission. Fever persisted and changes on
ultrasound and renal scan suggested acute rejection. Serum
creatinine had increased from 0.6 to 0.9 mg%. Renal biopsy was
performed. The patient was treated with 3 grams of i.v. Pred-
nisone. Serum creatinine decreased to 0.6 mg% and renal
function stabilized. The renal transplant is still functioning
adequately at the time of publication.
Group 3b (patients with biopsies and transplant nephrectom-
ies) Case numberS. A fifteen year old male who had previously
lost one cadaveric renal transplant secondary to chronic rejec-
tion seven years and eight months post-transplant received a
second antigen match cadaveric renal transplant. He was
treated with 3 g of iv. methylprednisolone and an increased
oral Prednisone dosage for acute rejection secondary to medical
non-compliance. On the eleventh post-transplant day he devel-
oped fever with deterioration of renal function. Four grams of
i.v. methylprednisolone were given over seven days. Fever
persisted intermittently but with negative viral cultures. Renal
function was poor, necessitating dialysis. His CMV antibody
titer had fallen from Monday 13 to 32 on day 18. Renal biopsies
were performed on days 20 and 44 and a nephrectomy was done
on day 48. Culture of the nephrectomy specimen revealed no
cytomegalovirus.
Case number 6. A 37 year old female on chronic hemodialysis
received a 0 antigen match cadaveric renal transplant. She was
treated for acute rejection commencing on the eighth post-
transplant day with 1 g of i.v. methyiprednisolone daily for four
days. Commencing on the 39th day she was again treated with
3 g of i.v. methylprednisolone for acute rejection. Renal func-
tion stabilized at a serum creatinine of 1.2 mg% by the 60th day
and the patient was discharged. On the 67th day she was
readmitted with a serum creatinine of 2.8 mg%, she was
afebrile, and had a white cell count of 8,200. Renal biopsies
were performed at day 38 and 70 days post-transplantation.
Renal function progressively deteriorated and transplant
nephrectomy was done on day 80. CMV antibody titer on day
74 was 2048, and a repeat titer on day 83, three days after the
transplant nephrectomy, was 1024.
Case number 7. A 38 year old male with end stage renal
disease, secondary to polycystic kidney disease, underwent a 1
antigen match cadaveric transplant. The first week after trans-
plantation the patient developed acute tubular necrosis neces-
sitating hemodialysis. Subsequent improvement occurred.
Twenty days post-transplant, his renal function deteriorated
with serum creatinine rising to 3.0 mg%. No fever or leukopenia
were noted. It was felt that he had developed acute rejection
and received 3 g of i.v. methylprednisolone. The atient's
improvement was not as expected, fever developed, and a renal
biopsy was then performed. Post-biopsy he was again treated
with 3 g of i.v. methylprednisolone and the graft function
improved to a serum creatinine of 2.2. Forty-six days post-
transplant, however, his creatinine increased again to 2.7,
suggesting a third acute rejection episode. No response was
obtained with aggressive anti-rejection therapy and a nephrec-
tomy was performed on day 52.
Materials and methods
Formalin fixed tissues from all autopsy and biopsy kidneys
were routinely embedded, sectioned, and examined using
hematoxylin and eosin, periodic-acid schiff, Masson's
trichrome, and Jones silver methenamine stains for light
microscopy.
Electron microscopy was performed on all renal specimens,
utilizing either buffered formalin or glutaraldehyde fixed tissue.
Electron microscopy specimens corresponding to renal biopsies
were fixed primarily in Carson's buffered formalin solution. All
electron microscopic specimens were postfixed in osmium-
tetroxide, embedded in low viscosity epoxy resin, sectioned
and stained with uranyl acetate and lead citrate. At least three
blocks of tissue were examined from each case, utilizing a
Hitachi HU 11-C transmission electron microscope (Tokyo,
Japan).
Immunofluorescent studies, utilizing a well characterized
anti-rabbit CMV antibody obtained from Polysciences Corpo-
ration (Warrington, Pennsylvania, USA) were performed on
cases from Group 3. Positive controls used included a lung with
Fig. 1. Hematoxylin and eosin stain, patient from Group 2 (infant) with
disseminated cytomegalovirus infection and tubular interstitial
nephritis. Note numerous intranuclear inclusions within the lining
tubular epithelial cells. (x 160)
cytomegalovirus pneumonitis and a cell culture infected with
cytomegalovirus. Negative controls used were a case of bacte-
rial pneumonia and non-infected epithelial cells in a cell culture.
Results
Group 1. Autopsy showed pathologic findings confirming
disseminated cytomegalovirus infection as noted in Table 1.
Examination of kidneys, however, failed to reveal any tubular,
interstitial, or glomerular findings indicative of cytomegalovirus
disease. Specifically, glomeruli were completely within normal
limits and there was no evidence of the lesion of cytomegalo-
virus glomerulopathy.
Group 2. Patients in this group showed autopsy evidence of
disseminated cytomegalovirus infection (Table 2) with definite
morphologic evidence of renal cytomegalovirus in nine pa-
tients. By far, the predominant pattern, however, was an acute
and chronic interstitial inflammation associated with unequivo-
cal cytomegalovirus inclusions within the tubular epithelial
cells. In only one case similar inclusions were seen within
glomerular visceral epithelial cells. Even in those cases associ-
ated with the most severe signs of renal infection, there was no
evidence of cytomegalovirus glomerulopathy (Fig. 1 & 2).
Group 3. On renal transplant biopsies, all seven patients
showed a peculiar, generalized, diffuse glomerulopathy charac-
terized by enlargement and necrosis of endothelial cells, accu-
mulation of fibrillary material in capillary spaces associated
with some infiltration of mononuclear cells (Fig. 3). In six of
these cases there was no associated acute vascular changes to
explain the glomerulopathy. In one case (case number 7), there
were focal and minimal changes of acute vascular rejection. The
changes were limited to one blood vessel (out of sixteen
sections) which showed mild residual acute vascular rejection.
In all cases, blood vessels showed the usual intimal fibrous
thickening characteristic of chronic vascular rejection.
Electron microscopy. Electron microscopic examination of
all specimens from these seven patients showed a diffuse
pattern of endothelial damage and degeneration associated with
fibrin deposition within expanded subendothelial areas and
Fig. 2. Hematoxylin and eosin stain, high power view of same patient
with cytomegalovirus tubular interstitial nephritis. Note absence of
glomerulopathy. (x 380)
sometimes within capillary spaces. Viral particles were not
present in any of the cases (Fig. 4).
Immunofluorescence. Routine immunofluorescent studies
showed the presence of prominent granular C3 staining in the
interstitial, vascular, and endothelial cell compartments along
the glomerular capillary loops in at least focal and segmental
areas in all seven cases. Stains for IgG, 1gM, IgA, and C4 were
negative in six cases. Case number 7 also showed focal,
segmental glomerular deposition of C3 and 1gM.
Immunofluorescent studies obtained on five of the seven
patients failed to reveal any evidence of cytomegalovirus anti-
gen except for a positive result which was rather focal, only in
a few tubules in case 6 (only in nephrectomy specimen—two
negative previous biopsies). No positive immunofluorescence
was noted in glomeruli of any of the cases.
Subsequent course
For validation of disease these renal biopsy cases were
divided into two groups: Group 3a, with validation of subse-
quent clinical course, without rebiopsy or nephrectomy; and
Group 3b, in which there was a subsequent nephrectomy.
Group 3A (Biopsy only, cases 1 through 4). Only one of these
four patients was cultured and he had a positive urine culture
for cytomegalovirus (Case 2). The four patients had measurable
EBV and/or CMV antibody titers, but rising titers were not
demonstrated due to lack of sequential specimens.
Cases 1, 2, and 4 had improved or stabilized renal function
under immunosuppressive therapy for rejection. It should be
noted that this includes the one patient (case number 2) whose
urine culture was positive for cytomegalovirus. None of these
four patients developed disseminated cytomegalovirus infection
despite therapy for rejection.
Group 3B (Biopsy and nephrectomy cases). These patients,
Cytomegalovirus glomerulopathy 729
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Fig. 3. A Periodic acid-Schiff(PAS) stain (x450). B Silver methenamine stain (x450). Patient from Group 3. Note in a early glomerulopathy
changes characterized by segmental obliteration of capillary spaces which are partially filled by webs of fibrillary material (arrows). There were
also occasional mononuclear cells within capillary spaces, as well as enlarged endothelial cells. In b note advanced glomerulopathy with prominent
webs of fibrillary material obliterating many capillary spaces (arrows).
orescence for CMV antigens was negative in two nephreetomy
specimens and equivocal positivity was noted in some tubules
in case number 6.
Group 4. In the first case, autopsy showed pulmonary, liver
and adrenal gland involvement with typical cytomegalovirus
inclusions, but no evidence of renal involvement. Specifically,
no glomerulopathy was noted. The second case showed an
acute tubular interstitial nephritis with typical cytomegalovirus
inclusions in tubular epithelial cells (Fig. 5). No glomerulopathy
was noted in either of these two cases (Fig. 6A). Viral particles
were demonstrated on ultrastructural examination of the af-
fected tubules (Fig. 6B & C) in the second case.
Summary of Results
Fig. 4. Uranyl acetate and lead acetate, electron micro graph from
patient from Group 3. Note expansion of subendothelial spaces with
fibrillary, fibrin-like material. Also note obliteration of capillary space
and enlarged endothelial cell on the right hand side. Note absence of
viral particles, (x 12,000)
cases 5, 6 and 7, had subsequent nephrectomies following
continued deterioration of renal function. None developed
evidence of disseminated cytomegalovirus infection but two
had measurable CMV antibody titers. Case number 5 showed a
mild acute interstitial rejection with a glomerulopathy but with
a negative tissue culture of renal tissue for cytomegalovirus.
Case number 6 showed a severe acute interstitial and capillary
rejection associated with the pre-existent glomerulopathy. Case
number 7 showed a florid acute vascular rejection. Immunoflu-
Groups 1 and 2 in this study represented a series of patients
with disseminated herpes virus infection, predominantly
cytomegalovirus, many in an immunocompromised status. Ex-
tensive examination of kidneys in these patients showed no
evidence of a glomerulopathy consistent with cytomegalovirus
glomerulopathy.
Group number 3, renal transplant patients with biopsies
suggestive of cytomegalovirus glomerulopathy, was the most
interesting group. Immunofluorescent examination of cytomeg-
alovirus antigen in five of the seven patients in which such
material was adequate showed no evidence of cytomegalovirus
within any of the glomerulopathies.
In group 3a, patients with a biopsy only, three of the patients
improved under anti-rejection therapy, and this included one
patient with a positive urine culture for cytomegalovirus. One
patient required reversion to hemodialysis without nephrectomy.
-
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Fig. 5. Hematoxylin and eosin stain, nephrectomy specimen from
kidney transplant recipient in Group 4 with cytomegalovirus tubular
interstitial nephritis. Note inflammatory interstitial component and on
the right hand side, a single eosinophilic intranuclear inclusion within a
lining tubular epithelial cell. Note absence of glomerulopathy in the
nearby glomerulus. (x87)
The three patients (cases 5, 6, and 7) who subsequently
required nephrectomy showed a varied picture. Case number 7
had florid acute vascular rejection which was suggested in the
first biopsy. The vascular rejection in the nephrectomy speci-
men was extremely severe. Case number 6 also showed a
severe acute vascular and interstitial rejection in the nephrec-
tomy specimen, changes not seen on the prior biopsy only ten
days before. There was no evidence of cytomegalovirus within
the kidney. These two cases, case numbers 6 and 7, evidently
represent cases of acute vascular rejection which was not
evident on biopsy, explaining the acute glomerulopathy.
Case number 5, on nephrectomy, showed only mild acute
interstitial rejection, retention of the previously seen
glomerulopathy, and once again no evidence of cytomegalovi-
rus infection. This included a negative culture for cytomegalo-
virus done on the nephrectomy tissue. The cause of the
glomerulopathy in this patient is unexplained. It does not
appear to have any evidence of relationship to cytomegalovirus
infection.
The two immunosuppressed kidney transplant recipients
(Group 4) failed to show any evidence of glomerulopathy or
significant active vascular or interstitial rejection. The cause of
death in the first case was disseminated cryptococcosis, and the
loss of the transplanted kidney in the second case was related to
the severe acute tubular interstitial nephritis identified.
Discussion
A total of 78 kidney biopsies were performed at the Univer-
sity of Alabama in Birmingham during a 16 month period
(1982—1983) in patients who had received kidney transplants, to
evaluate possible rejection or other pathology. Of these, seven
cases were found to show a peculiar generalized, diffuse
glomerulopathy characterized by enlargement and necrosis of
endothelial cells and accumulation of fibrillary material in
capillary spaces, sometimes associated with mononuclear cells.
In these cases (except for one in which focal vascular changes
later confirmed to represent acute vascular rejection were
seen), there were no acute vascular rejection changes to explain
the glomerular necrotizing changes observed. Their clinical
pictures were variable. The changes in the renal biopsies were
similar to those described by Richardson et al [1], and on this
basis it was felt that the biopsies could represent cytomegalo-
virus glomerulopathy. However, positive immunofluorescence
for cytomegalovirus or definite inclusions identifiable by light
microscopy were not noted, and on extensive electron
micrscopic examination, viral particles could not be found in
glomeruli or interstitial locations. In addition, the glomerular
changes identified in these cases were compared with glomer-
ular changes identified in other transplant recipient biopsies
with acute vascular rejection and associated transplant
glomerulopathy (classical transplant glomerulopathy). The mor-
phological changes noted in the glomeruli were indistinguish-
able when both subgroups were analyzed.
A study was then designed to determine if such changes
indeed represent a glomerulopathy which is specifically associ-
ated with cytomegalovirus or herpes infection in general, or if
they could represent a form of unusual rejection. It has been
suggested that immunosuppressive therapy be reduced if the
lesion consistent with cytomegalovirus glomerulopathy is pres-
ent. However, if this lesion instead represents a peculiar pat-
tern of acute rejection, increased immunosuppression may be
indicated.
Four basic mechanisms of injury can be postulated as causing
a glomerulopathy associated with cytomegalovirus infection.
Actual renal colonization by cytomegalovirus has been sug-
gested, though previous reports have never really supported
this possibility and this study is equally nonsupportive. Support
for this theory of colonization, however, is found on cases of
cytomegalovirus associated with tubular interstitial nephritis
[5]. A toxic effect of disseminated CMV infection resulting in
direct endothelial cell damage is another possible mechanism.
There are several infectious agents —rickettsiae and also some
viruses which can cause endothelial cell damage as the predom-
inant manifestion of disease. This study provided no evidence
of this process being present in Groups 1, 2 or 4 where there
was well documented disseminated CMV infection, which
makes this possibility unlikely.
A third mechanism which may be responsible for the
glomerulopathy is that of an immune-complex mediated process
as has been reported by Ozawa et al [6] in a single patient.
However, no immune complexes or significant CMV
antigenemia were demonstrated in any of the cases from the
four groups studied. A peculiar rejection phenomena, perhaps
triggered by the systemic cytomegalovirus infection, is the
fourth possibility and the most attractive. It is well known and
described that cytomegalovirus affects host immunologic re-
sponses, so that it is possible that cytomegalovirus infection in
a renal transplant patient could alter the rejection process.
Acute viral infections and alloantigen stimulation occurring at
the same time may act synergistically, activating T cells, which
may lead to generation of mature cytotoxic T lymphocytes and
other effector cells. Such a mechanism has been reported by
several authors [7—9]. Lopez et al in 1974 suggested that
cytomegalovirus infections in renal transplant recipients and
subsequent renal deterioration may be due to triggering a
rejection phenomena [10]. Tourkantonis and Lazaridis have
discussed extensively the immunologic mechanisms that may
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Fig. 6. Uranyl acetate and leadcitrate electron micrographs corresponding to the same case illustrated in Figure 5. A note normal ultrastructural
glomerular appearance in the previously shown unremarkable glomerulus adjacent to tubule with well defined cytomegalovirus inclusion. Note
absence of viral particles (x6500) B Note viral particles identified within affected lining tubular epithelial cells primarily in their cytoplasm. Note
cytnpathic cellular changes as well (x67,500). C Note details of viral particles in this detail of B.
be involved in this interaction Ill]. Life table analyses have
suggested a trend of decreased allograft survival with
cytomegalovirus infection in transplant recipients, but the dif-
ference with controls has not proven to be statistically signifi-
cant [12]. In contrast, other studies have shown that overt
cytomegalovirus disease was associated with a significantly
incrcased incidence of transplant nephrcctomy and death [13].
A similar morphologic pattern of glomerular injury to that
described in association with "cytomegalovirus glomerulop-
athy" has been associated with hyperacute rejection, and
antibodies against endothelial cells have been implicated as
possibly important in the pathophysiologic mechanism. Cerilli
et al 114] have reported preliminarily that in recipients of related
donor renal allografts, the presence or absence of an IgG
antibody targeted for the vascular endothelial cell (VEC) cor-
relates significantly with clinical course and survival of the
graft. Hirschberg data [15, 16] as well as Cerilli [14, 17] indicate
that endothelial cells possess antigenic sites that are distinct
from those present on lymphocytes (i.e., non—HLA),
Hirschherg et al [15] have shown that endothelial cells are
capable of serving as target cells in in vitro cell mediated
antibody dependent cytotoxic reactions. Further characteriza-
tion of the vascular/endothelial cell compartment and the im-
munologic response to it may be important in explaining the
pattern of glomerular injury that the authors have observed in
the Group 3 cases.
Furthermore, Zollinger et al [18] emphasize that cytomega-
lovirus must be diligently sought for in transplant nephrectomy
and autopsies in tubular epithelium. They were only able to
demonstrate cytomegalovirus histologically once, even though
the virus had been demonstrated in the urine of three patients.
In contrast, in newborns and children with severe
cytomegalovirus infection, a focal segmental necrotizing gb-
merulonephritis can be seen; in those cases, typical inclusions
can usually be demonstrated in endothelial or tubular lining
epithelial cells. Multinucleation of visceral epithelial and even
endothelial cells can be observed in such cases. However, in
those cases in which transmission electron microscopy has
been attempted, the DNA virus can be demonstrated unequiv-
ocally in the affected tubular or glomerular cells. Zollinger's
study [18] suggests that cytomegalovirus infection is usually not
associated with glomerular involvement when it occurs in
patients immunosuppressed in general, including those after
renal transplantation. In one case from Group 1, there was no
glomerulopathy in spite of the glomerular inclusions found.
Experimental work has suggested a specific effect for
cytomegalovirus with acute infections producing a transient
glomerular change restricted to the mesangium and character-
ized by a mesangiopathic glomerulopathy associated with im-
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mune complex deposition [19]. A case in the series of post-
perfusion cytomegalovirus infection by Kantor et al also
showed a mesangiopathic process [20]. In the cases that we
studied, there was no evidence of an immune-complex medi-
ated glomerulopathy.
The seventh case identified in our group of renal biopsies
(Group 3) was quite peculiar. This case showed findings con-
sistent with cytomegalovirus glomerulopathy. There was only
one vessel identified with residual acute vascular rejection. The
other vessels only showed intimal fibrous thickening, indicative
of chronic vascular rejection. This patient responded poorly
following acute rejection protocol treatment and eventually lost
the kidney. The nephrectomy specimen showed severe dissem-
inated acute vascular rejection. If due to sampling artifact, this
involved vessel had not been present in the biopsy, the
glomerulopathy would have been considered suggestive of
cytomegalovirus glomerulopathy. This case illustrates that at
least some of the so-called "cytomegalovirus glomerulopathy"
cases represent acute vascular rejection which is not detectable
in the biopsy specimens.
Transplant glomerulopathy has been shown to be quite
heterogeneous with a great variety of morphological expres-
sions varying from non-proliferative to proliferative to
necrotizing lesions [3, 4, 21, 22]. The findings in the cases
reported in this paper would be considered by some authors as
representing "cytomegalovirus glomerulopathy" and would fall
within the expected range of glomerular alterations already
described associated with transplant glomerulopathy [22]. A
distinct type of rejection pattern with glomerular lesions, inter-
preted as early graft damage has been recently reported [4].
This lesion is quite similar, if not the same, as the one the
authors found in Group 3 patients.
The authors found no evidence to suggest support that
cytomegalovirus glomerulopathy represents a specific entity. It
is the authors' opinion that the entity that has been considered
as cytomegalovirus glomerulopathy probably represents a pe-
culiar pattern of rejection which could be, at least in some
cases, associated with the presence of anti-endothelial cell
antibodies, and in others with a protracted, early, or partially
resolved acute vascular rejection. This type of rejection, how-
ever, could possibly be triggered by viral infections, such as
cytomegalovirus, as well as perhaps by other events.
"Cytomegalovirus glomerulopathy" should be considered a
peculiar "transplant glomerulopathy" with the clear under-
standing that this entity refers to a type of rejection and not to
a specific cytomegalovirus infection.
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